# FDA Inspection 1003985 - Biomat USA, Inc. - February 28, 2017

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/18c8faf4-5c0e-4d3e-bf8a-febd8e79d1ae
Source feed: FDA_Inspections

> FDA Inspection 1003985 for Biomat USA, Inc. on February 28, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1003985
- Company Name: Biomat USA, Inc.
- Inspection Date: 2017-02-28
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1191245 - 2022-11-10](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/b4e535b6-324e-4868-8919-3a343abd545b)
- [FDA Inspection 1191245 - 2022-11-10](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/3a74689c-9bb2-4e3c-bcd4-b1e590631aa3)
- [FDA Inspection 887583 - 2014-07-17](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/1b2c7f39-a848-4f10-9aa7-7f7d3c72722d)
- [FDA Inspection 787988 - 2012-06-13](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/bc7b53db-db26-43d0-9581-2003d19a624e)
- [FDA Inspection 680224 - 2010-08-20](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/d7738282-92ec-4d34-8ba6-0dbcbe622a7c)

Company: https://www.keypedia.com/companies/biomat-usa-inc/ceefd017-3511-4600-8ca4-5d27d018976f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d